Overview

Improving Treatment and Retention Adherence in Nontraditional Settings

Status:
Not yet recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
I-TRAINS aims to integrate an injectable treatment that is approved for HIV to individuals outside of the standard doctors office or clinic. The treatment, a once a month injection, will be administered to participants in community partner spaces, reducing the barriers that having to present to a traditional clinic for treatment creates. Individuals who will receive the injection may have a history of being unable to take their HIV oral medication, as well as other barriers to care that make it difficult to engage in a traditional clinic setting. These barriers may include, but are not limited to, homelessness, substance use, mental illness, and stigma around their diagnosis. Data will be collected on whether it was easier for the participants to receive care in a non-traditional setting, as well as whether the injection made it easier for them to remain adherent to their HIV medication in comparison to standard oral HIV medication.
Phase:
Phase 4
Details
Lead Sponsor:
Boston Medical Center
Collaborator:
ViiV Healthcare
Treatments:
Cabotegravir